NasdaqGS - Delayed Quote USD
Akoya Biosciences, Inc. (AKYA)
1.1400
-0.0200
(-1.72%)
At close: June 5 at 4:00:01 PM EDT
1.1900
+0.05
+(4.39%)
After hours: June 5 at 7:53:38 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 4 |
| Avg. Estimate | -0.23 | -0.2 | -0.87 | -0.5 |
| Low Estimate | -0.23 | -0.2 | -0.87 | -0.63 |
| High Estimate | -0.23 | -0.2 | -0.87 | -0.34 |
| Year Ago EPS | -0.27 | -0.18 | -0.96 | -0.87 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 4 | 7 |
| Avg. Estimate | 18.1M | 20.2M | 83.25M | 97.98M |
| Low Estimate | 18.1M | 20.2M | 77.5M | 90.9M |
| High Estimate | 18.1M | 20.2M | 87.6M | 111.61M |
| Year Ago Sales | 23.16M | 18.81M | 81.67M | 83.25M |
| Sales Growth (year/est) | -21.86% | 7.37% | 1.94% | 17.68% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.27 | -0.2 | -0.16 | -0.23 |
| EPS Actual | -0.27 | -0.18 | -0.17 | -0.32 |
| Difference | 0 | 0.02 | -0.01 | -0.09 |
| Surprise % | 1.59% | 11.39% | -4.63% | -39.13% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.23 | -0.2 | -0.87 | -0.5 |
| 7 Days Ago | -0.16 | -0.12 | -0.6 | -0.45 |
| 30 Days Ago | -0.16 | -0.13 | -0.62 | -0.48 |
| 60 Days Ago | -0.17 | -0.14 | -0.62 | -0.46 |
| 90 Days Ago | -0.17 | -0.14 | -0.62 | -0.46 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | 1 | 1 | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| AKYA | 14.81% | -11.98% | 9.03% | 42.83% |
| S&P 500 | 13.12% | 2.46% | 7.55% | 13.98% |
Upgrades & Downgrades
| Maintains | Canaccord Genuity: Hold to Hold | 5/19/2025 |
| Maintains | Canaccord Genuity: Hold to Hold | 4/29/2025 |
| Maintains | Piper Sandler: Neutral to Neutral | 4/14/2025 |
| Downgrade | Stephens & Co.: Overweight to Equal-Weight | 3/25/2025 |
| Reiterates | Stephens & Co.: Overweight to Overweight | 3/18/2025 |
| Reiterates | Piper Sandler: Overweight to Overweight | 11/19/2024 |
Related Tickers
POAI Predictive Oncology Inc.
0.9500
-0.78%
MHUA Meihua International Medical Technologies Co., Ltd.
0.6148
+9.38%
OTCFF Ocumetics Technology Corp.
0.2605
0.00%
DIM.PA Sartorius Stedim Biotech S.A.
193.85
+0.08%
FEMY Femasys Inc.
0.8000
0.00%
ZJYL Jin Medical International Ltd.
0.7933
-0.81%
STAA STAAR Surgical Company
17.40
+4.38%
STSS Sharps Technology, Inc.
5.79
-8.24%
BNGO Bionano Genomics, Inc.
3.6800
-0.54%
INND InnerScope Hearing Technologies, Inc.
0.0046
+22.13%